SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST
Sarcoma Alliance for Research through Collaboration
Sarcoma Alliance for Research through Collaboration
Columbia University
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center and Research Institute